Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia

European Journal of Endocrinology

Volumn 145, Issue 6, 2001, Pages 727-735

  Doehner, W ^a   Pflaum, C D ^a   Rauchhaus, M ^a   Godsland, I F ^a   Egerer, K ^a   Cicoira, M ^a   Florea, V G ^a   Sharma, R ^a   Bolger, A P ^a   Coats, A J S ^a   Anker, S D ^a   Strasburger, C J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENE PRODUCT; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; INSULIN; LEPTIN; NITRIC ACID DERIVATIVE; RECOMBINANT GROWTH HORMONE; WARFARIN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLIC DISORDER; MODEL; ORGAN SIZE; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; REGRESSION ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

EID: 0035210722     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450727     Document Type: Article

References (45)

1. Growth hormone receptor and serum binding protein: Purification, cloning and expression
2. Growth hormone-binding proteins in plasma
3. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor
4. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery
5. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
6. Role of growth hormone in chronic heart failure. Therapeutic implications
7. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: Correlation with GH insensitivity
8. Nutritional status and growth hormone-binding protein
9. Serum growth hormone-binding protein in obesity: Effect of a short-term, very low calorie diet and diet-induced weight loss
10. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults
11. GH-binding protein in obese men with varying glucose tolerance: Relationship to body fat distribution, insulin secretion and the GH-IGF-I axis
12. Growth hormone-binding protein directly depends on serum leptin levels in adults with different nutritional status
13. Identification and expression cloning of a leptin receptor, OB-R
14. Abnormal splicing of the leptin receptor in diabetic mice
15. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
16. Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children
17. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response
18. Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin
19. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
20. The role of leptin in human physiology
21. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
22. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
23. Heart failure as a metabolic problem
24. Hyperleptinaemia in chronic heart failure. Relationships with insulin
25. Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure
26. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
27. Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation
28. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure
29. Assessment of insulin sensitivity in man: A comparison of minimal model and euglycaemic clamp derived measures in health and heart failure
30. Quantitative estimation of insulin sensitivity
31. Sex- and menopause-associated changes in body fat distribution
32. Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood
33. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of the effects of age and obesity
34. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
35. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction
36. Leptin is involved in gender-related differences in insulin sensitivity
37. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure
38. Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig
39. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
40. Serum leptin concentration in heart failure patients: Does the literature reflect reality?
41. Ontogeny and nutritional regulation of the serum growth hormone-binding protein in the rat
42. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-1 (IGF-I), and IGF-I receptors in obesity and anorexia nervosa
43. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus
44. A placebo-controlled study of growth hormone in patients with congestive heart failure
45. Low leptin gene expression and hyperleptinemia in chronic renal failure